Welcome from the Director
Cancer rates in Ireland have been ranked third highest in the world in recent years. The National Cancer Registry Ireland reports that cancer incidence in Ireland continues to rise over the years, although advances in early detection and treatment have contributed to improved survival overall. Many more people are living with and beyond a diagnosis of cancer and have unique needs to minimise symptom burden and maximise quality of life.
Despite recent advances, a proportion of patients experience disease recurrence after treatment for early stage cancer, or indeed present with advanced disease. Novel cancer diagnostics, therapeutics and other interventions are therefore urgently required in order to innovate in the areas of cancer prevention, early detection, prevention and management of recurrent disease, focusing on a “personalised” approach to cancer care.
Our goal at Cancer Research @UCC is to improve cancer outcomes through innovative research programmes spanning the bench to the bedside. Our 1600m2 translational cancer research complex situated in the Western Gateway Building, University College Cork, is home to both laboratory-based and clinician scientists. The centre is also the academic home for the HRB-funded UCC Cancer Trials Group, which spans clinical trials units across the region, and the Cork arm of the Blood Cancer Network Ireland.
Our team collaborates with cancer researchers across UCC, spanning the Schools of Medicine, Public Health, Pharmacy, Pharmacology and Therapeutics, Pathology, Biochemistry and Cell Biology, Science Engineering and Food Science amongst others. Support from UCC’s College of Medicine & Health has been imperative to our success in recent years, as well as from our academic, charity, patient and industry partners.
By working together we believe that we can improve outcomes for those at risk of or living with cancer both in Ireland and beyond, in line with the National Cancer Strategy 2017 and Europe’s Beating Cancer Plan.
Roisin M. Connolly MB BCh MD
Professor Gerald O'Sullivan Chair in Cancer Research